QuiaPEG Pharmaceuticals operates in medical technology. The company has developed a technological platform that is used to improve and develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Alex Cohen | 5,82 | 5,82 | 2024-06-26 |
| Sarum Sok | 4,26 | 4,26 | 2024-06-26 |
| Johan Thorell | 3,73 | 3,73 | 2024-06-26 |
| Avanza Pension | 3,62 | 3,62 | 2024-06-26 |
| Michael Fogelberg med familj | 2,04 | 2,04 | 2024-06-26 |
| Urban Alm | 2,01 | 2,01 | 2024-06-26 |
| Erik Fällström via bolag | 1,42 | 1,42 | 2024-06-26 |
| Simon Dagarsson | 1,39 | 1,39 | 2024-06-26 |
| Nordnet Livsforsikring AS | 1,36 | 1,36 | 2024-06-26 |
| Bengt Reinius | 1,34 | 1,34 | 2024-06-26 |
